ArticleWorld journal of microbiology & biotechnology2025
Antifungal activity and genome annotation of Bacillus amyloliquefaciens subsp. plantarum SMLR1, a potential biocontrol agent of Rhizoctonia solani.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Potential of Bacillus amyloliquefaciens XSZ-1 as a bio-inoculant for enhancing cotton productivity and health in saline-alkali cotton field soil.World journal of microbiology & biotechnology · 2026Article
- Integrated genomics, metagenomics and metatranscriptomics to reveal the biocontrol mechanism ofFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential use of 172 Solanaceae seed-borne endophytic bacteria strains for biocontrol of Rhizoctonia solani was investigated. Most strains (88.95%) showed an early antifungal effect, but only 27.91% exhibited persistent activity at 14 days via soluble compounds against R. solani. Thirty-two selected strains with high antifungal activity were tested for plant growth promotion on tomato seedlings, hydrolytic enzymes production, phosphate solubilization, and siderophore production. The strain SMLR1 combined high and persistent antifungal activity with the most positive effect on tomato seedlings' hypocotyl and radicle lengths. This strain produced antifungal lipopeptides extracted after 66 h of culture, with an effective concentration 50% (EC50) ranging from 27 to 98 µg/mL against various R. solani strains. Genome analysis of SMLR1 revealed it belongs to Bacillus amyloliquefaciens subsp. plantarum, with diverse biosynthetic gene clusters associated with non-ribosomal peptides (NRPs), lipopeptides (fengycin and surfactin), siderophores, bacteriocins, β-lactones, type III polyketide synthases (T3PKS), terpenes, and antimicrobial compounds. These findings highlight the potential of B. amyloliquefaciens subsp. plantarum SMLR1 as a biocontrol agent for R. solani, with whole genome sequencing offering a cost-effective way for rapid genomic selection of biocontrol agents.
Indexed as
Identifiers
41171481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.